Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Augmenting the synergies of chemotherapy and immunotherapy through drug delivery.

Kim J, Manspeaker MP, Thomas SN.

Acta Biomater. 2019 Apr 1;88:1-14. doi: 10.1016/j.actbio.2019.02.012. Epub 2019 Feb 12. Review.

PMID:
30769136
3.

Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.

Kersh AE, Ng S, Chang YM, Sasaki M, Thomas SN, Kissick HT, Lesinski GB, Kudchadkar RR, Waller EK, Pollack BP.

J Clin Pharmacol. 2018 Jan;58(1):7-24. doi: 10.1002/jcph.1028. Epub 2017 Nov 14. Review.

4.

Correction to: Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide.

Palao-Suay R, Rosa Aguilar M, Parra-Ruiz FJ, Martín-Saldaña S, Rohner NA, Thomas SN, San Román J.

J Mater Sci Mater Med. 2017 Nov;28(11):182. doi: 10.1007/s10856-017-5995-3. No abstract available.

PMID:
29027159
5.

Multifunctional decoration of alpha-tocopheryl succinate-based NP for cancer treatment: effect of TPP and LTVSPWY peptide.

Palao-Suay R, Aguilar MR, Parra-Ruiz FJ, Martín-Saldaña S, Rohner NA, Thomas SN, San Román J.

J Mater Sci Mater Med. 2017 Aug 31;28(10):152. doi: 10.1007/s10856-017-5963-y.

PMID:
28861765
6.

Photothermal and photodynamic activity of polymeric nanoparticles based on α-tocopheryl succinate-RAFT block copolymers conjugated to IR-780.

Palao-Suay R, Martín-Saavedra FM, Rosa Aguilar M, Escudero-Duch C, Martín-Saldaña S, Parra-Ruiz FJ, Rohner NA, Thomas SN, Vilaboa N, San Román J.

Acta Biomater. 2017 Jul 15;57:70-84. doi: 10.1016/j.actbio.2017.05.028. Epub 2017 May 13.

7.

Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy.

Francis DM, Thomas SN.

Adv Drug Deliv Rev. 2017 May 15;114:33-42. doi: 10.1016/j.addr.2017.04.011. Epub 2017 Apr 25. Review.

8.

Enhanced Bioactivity of α-Tocopheryl Succinate Based Block Copolymer Nanoparticles by Reduced Hydrophobicity.

Palao-Suay R, Aguilar MR, Parra-Ruiz FJ, Maji S, Hoogenboom R, Rohner NA, Thomas SN, Román JS.

Macromol Biosci. 2016 Dec;16(12):1824-1837. doi: 10.1002/mabi.201600259. Epub 2016 Oct 14.

9.

Force and torque on spherical particles in micro-channel flows using computational fluid dynamics.

Suo J, Edwards EE, Anilkumar A, Sulchek T, Giddens DP, Thomas SN.

R Soc Open Sci. 2016 Jul 27;3(7):160298. doi: 10.1098/rsos.160298. eCollection 2016 Jul.

10.

α-Tocopheryl succinate-based amphiphilic block copolymers obtained by RAFT and their nanoparticles for the treatment of cancer.

Palao-Suay R, Aguilar MR, Parra-Ruiz FJ, Maji S, Hoogenboom R, Rohner NA, Thomas SN, Román JS.

Polym Chem. 2016 Jan 28;7(4):838-850. Epub 2015 Nov 27.

11.

Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy.

Thomas SN, Rohner NA, Edwards EE.

Annu Rev Biomed Eng. 2016 Jul 11;18:207-33. doi: 10.1146/annurev-bioeng-101515-014413. Epub 2016 Feb 24. Review.

12.

Analytical cell adhesion chromatography reveals impaired persistence of metastatic cell rolling adhesion to P-selectin.

Oh J, Edwards EE, McClatchey PM, Thomas SN.

J Cell Sci. 2015 Oct 15;128(20):3731-43. doi: 10.1242/jcs.166439. Epub 2015 Sep 8.

13.

S-Nitrosated Polypropylene Sulfide Nanoparticles for Thiol-Dependent Transnitrosation and Toxicity Against Adult Female Filarial Worms.

Schudel A, Kassis T, Dixon JB, Thomas SN.

Adv Healthc Mater. 2015 Jul 15;4(10):1484-90, 1423. doi: 10.1002/adhm.201400841. Epub 2015 May 4.

14.
15.

Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.

Thomas SN, Vokali E, Lund AW, Hubbell JA, Swartz MA.

Biomaterials. 2014 Jan;35(2):814-24. doi: 10.1016/j.biomaterials.2013.10.003. Epub 2013 Oct 18.

16.

Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage.

Thomas SN, Rutkowski JM, Pasquier M, Kuan EL, Alitalo K, Randolph GJ, Swartz MA.

J Immunol. 2012 Sep 1;189(5):2181-90. doi: 10.4049/jimmunol.1103545. Epub 2012 Jul 27.

17.

VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.

Lund AW, Duraes FV, Hirosue S, Raghavan VR, Nembrini C, Thomas SN, Issa A, Hugues S, Swartz MA.

Cell Rep. 2012 Mar 29;1(3):191-9. doi: 10.1016/j.celrep.2012.01.005. Epub 2012 Feb 23.

18.

Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis.

Dallas MR, Liu G, Chen WC, Thomas SN, Wirtz D, Huso DL, Konstantopoulos K.

FASEB J. 2012 Jun;26(6):2648-56. doi: 10.1096/fj.12-203786. Epub 2012 Mar 13. Erratum in: FASEB J.2012 Nov;26(11):4774.

19.

Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages.

Yu SS, Lau CM, Thomas SN, Jerome WG, Maron DJ, Dickerson JH, Hubbell JA, Giorgio TD.

Int J Nanomedicine. 2012;7:799-813. doi: 10.2147/IJN.S28531. Epub 2012 Feb 15.

20.

PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma.

Velluto D, Thomas SN, Simeoni E, Swartz MA, Hubbell JA.

Biomaterials. 2011 Dec;32(36):9839-47. doi: 10.1016/j.biomaterials.2011.08.079. Epub 2011 Sep 15.

PMID:
21924769

Supplemental Content

Loading ...
Support Center